Inventiva IVA
NASDAQ IVA
$3.57 -0.13 (-3.39%)
As of: Oct 1, 2026 · 12:39 PM EDT

Inventiva (IVA) Other Non-Current Liabilities (2022 - 2026)

Updated

Inventiva's Other Non-Current Liabilities was $15.17 million in Q2 2026, compared with $1.27 million a year earlier.

Analysis

Inventiva (IVA) Other Non-Current Liabilities (2022 - 2026) Analysis & Trends

At the end of FY2025, Other Non-Current Liabilities at Inventiva came in at $15.19 million.

  • Other Non-Current Liabilities shows a three-year compound annual growth rate of 14.7% (FY2022 to FY2025).
  • In earlier years, Other Non-Current Liabilities was $1.1 million in FY2024 (-0.7%), $1.11 million in FY2023 (-89.0%) and $10.08 million in FY2022.
  • Quarterly Other Non-Current Liabilities has moved between $1.1 million (Q4 2024) and $15.19 million (Q4 2025) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Inventiva 713.04 Mn 713.04 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 15.17 Mn
Dec 31, 2025 1.39 Bn
Jun 30, 2025 1.27 Mn
Dec 31, 2024 1.10 Mn
Jun 30, 2024 14.61 Mn
Dec 31, 2023 1.11 Mn
Jun 30, 2023 8.99 Mn
Dec 31, 2022 10.08 Mn
API Access

Inventiva Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=IVA&period=max&api_key=YOUR_API_KEY